Caitong International Asset Management Co., LTD Kal Vista Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 157 shares of KALV stock, worth $1,496. This represents 0.0% of its overall portfolio holdings.
Number of Shares
157
Previous 157
-0.0%
Holding current value
$1,496
Previous $1.33 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding KALV
# of Institutions
135Shares Held
52MCall Options Held
551KPut Options Held
98K-
Vr Adviser, LLC New York, NY6.25MShares$59.6 Million7.5% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$46.8 Million1.73% of portfolio
-
Vestal Point Capital, LP New York, NY4.77MShares$45.5 Million2.4% of portfolio
-
Tang Capital Management LLC San Diego, CA4.32MShares$41.2 Million4.26% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.69MShares$35.1 Million2.3% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $234M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...